Robert Doody – Biography
Last update: April 16, 2026Executive profile
Robert was Vice President, Investor Relations at Provention Bio, and Senior Vice President, Investor Relations and Corporate Communications at Aceragen. Robert Doody joined Prelude Therapeutics in 2022.
Robert Doody is currentlySenior Vice President, Investor Relations at Prelude Therapeutics - View - Prelude Therapeutics org chart
Create your alert
to follow the career of Robert Doody.
Education
In 2002, Robert Doody completed a Bachelor of Arts in Communications at Rowan University.
They have also studied at Rowan University :
Find more alumni from Rowan University
More about Robert Doody
Do you need to know more about Robert Doody? More results.
Participate
Social media
- Robert Doody on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Robert Doody
The colleagues of Robert Doody
Company Colleagues
- At Prelude Therapeutics, Robert Doody has 18 colleagues including Kris Vaddi (CEO & Director), Paul Scherer (Director)…
Industry Colleagues
- In the Biotechnology industry, Robert Doody has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Robert Doody.
Get in Touch
Here are a few tips for establishing great contacts.
